GlucotrackGCTK
13F holders, Q1 2026 (March 31)13holders +3
3new positions
1sold out
$0.65avg. 13F price*
At the end of Q1 2026, 13 institutions reported holding Glucotrack Inc. (GCTK) in their 13F filings, up 3 from Q4 2025. 3 opened new positions and 1 sold out. The largest holders were Geode Capital Management, LLC ($31K), Ikarian Capital, LLC ($30K) and HRT Financial LP ($26K).
- Company
- Glucotrack Inc.
- CUSIP
- 45824Q804
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $57K |
| Exits | 1 | $108 |
All 13F filers, Q4 2025 → Q1 2026: 91,234 shares bought and 28 shares sold, net +91,206 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Geode Capital Management, LLC | 0.00% | New | 47,001 | $31K |
| Ikarian Capital, LLC | 0.00% | No change | 45,830 | $30K |
| HRT Financial LP | 0.00% | New | 40,631 | $26K |
| Boothbay Fund Management, LLC | 0.00% | No change | 13,525 | $9K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 4,722 | $3K |
| Alerus Financial NA | 0.00% | No change | 4,000 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +709.9% | 3,442 | $2K |
| UBS Group AG | 0.00% | Add +489.9% | 702 | $456 |
| NFSG Corp | 0.00% | No change | 34 | $22 |
| SBI Securities Co., Ltd. | 0.00% | No change | 9 | $6 |
| Morgan Stanley | 0.00% | No change | 1 | $1 |
| Osaic Holdings, Inc. | 0.00% | Add +100.0% | 2 | $1 |
| Royal Bank of Canada | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is GCTK's weight in each manager's 13F, not the share of Glucotrack Inc. the manager owns.